Atlas Trials

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Clinical trial NCT05442567 · RECRUITING

Trial details

NCT number
NCT05442567
Sponsor
Takeda
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Ulcerative ColitisCrohn's Disease
Start date
2023-05-16
Primary completion
2033-02-07
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.